Last updated on June 2020

PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostate Cancer | Recurrent | Prostate Disorders | Prostatic disorder | Malignant neoplasm of prostate | Early
  • Age: Between 18 - 100 Years
  • Gender: Male

Inclusion Criteria (surgery cohort):

  • Prostate cancer patients with biochemical relapse in accordance with the European Association of Urology (EAU) guidelines on prostate cancer; two consecutive measurements with PSA 0.2 ng/ml following radical prostatectomy or PSA > 2.0 ng/ml above the nadir following definitive radiotherapy
  • Potential candidates for loco-regional pelvic salvage treatment based on age and co-morbidity

Exclusion Criteria:

  • Previous salvage therapy for recurrent prostate cancer
  • General contra-indications for an MRI exam (pacemaker, aneurysm clips, any form of metal in the body, or severe claustrophobia)
  • Serious concomitant systemic disorders or reduced cognitive functioning that in the opinion of the investigator would compromise the patient's ability to complete the study or interfere with the evaluation of the efficacy and safety of the study objectives
  • Impaired renal function defined as estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73 m2
  • Hormonal treatment during the last three months

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.